key: cord-0807117-beinftme
authors: Marano, Jeffrey M.; Chuong, Christina; Weger-Lucarelli, James
title: Rolling circle amplification: A high fidelity and efficient alternative to plasmid preparation for the rescue of infectious clones.
date: 2020-09-28
journal: Virology
DOI: 10.1016/j.virol.2020.08.016
sha: d66b03dcb4c9c53289ccaddbc1a05ba1e67a967d
doc_id: 807117
cord_uid: beinftme

Alphaviruses (genus Alphavirus; family Togaviridae) are a medically relevant family of viruses that include chikungunya virus and Mayaro virus. Infectious cDNA clones of these viruses are necessary molecular tools to understand viral biology. Traditionally, rescuing virus from an infectious cDNA clone requires propagating plasmids in bacteria, which can result in mutations in the viral genome due to bacterial toxicity or recombination and requires specialized equipment and knowledge to propagate the bacteria. Here, we present an alternative-rolling circle amplification (RCA), an in vitro technology. We demonstrate that the viral yield of transfected RCA product is comparable to midiprepped plasmid, albeit with a slight delay in kinetics. RCA, however, is cheaper and less time-consuming. Further, sequential RCA did not introduce mutations into the viral genome, subverting the need for glycerol stocks and retransformation. These results indicate that RCA is a viable alternative to traditional plasmid-based approaches to viral rescue.

necessary molecular tools to understand viral biology. Traditionally, rescuing virus from an 11 infectious cDNA clone requires propagating plasmids in bacteria, which can result in mutations 12

in the viral genome due to bacterial toxicity or recombination and requires specialized equipment 13 and knowledge to propagate the bacteria. Here, we present an alternative-rolling circle 14 amplification (RCA), an in vitro technology. We demonstrate that the viral yield of transfected 15 RCA product is comparable to midiprepped plasmid, albeit with a slight delay in kinetics. RCA, 16 however, is cheaper and less time-consuming. Further, sequential RCA did not introduce 17 mutations into the viral genome, subverting the need for glycerol stocks and retransformation. 18

These results indicate that RCA is a viable alternative to traditional plasmid-based approaches to 19 viral rescue. 20 Importance 21

The development of infectious cDNA clones is critical to studying viral pathogenesis and for 22 developing vaccines. The current method for propagating clones in bacteria is limited by the 23 toxicity of the viral genome within the bacterial host, resulting in deleterious mutations in the 24 viral genome, which can only be detected through whole-genome sequencing. These mutations 25 can cause unexpected and unwanted results leading to wasted time and resources. To that end, 26

we have developed an alternative method of preparing large quantities of DNA that can be 27 directly transfected to recover infectious virus without the need for bacteria by amplifying the 28 infectious cDNA clone plasmid using rolling circle amplification (RCA). Our results indicate 29 confluency using the JetOptimus (Polyplus) DNA transfection reagent per manufacturer's 90 instructions. Briefly, we mixed 200 µl of JetOptimus buffer with the DNA concentration of 91 interest. JetOptimus reagent was then added at a ratio of 1 µl per 1 µg of DNA and incubated at 92 room temperature for 10 minutes. The transfection mix was then added dropwise into the wells 93 containing cells. We collected the supernatant at different time points based on the experiment: 94 each day for three days for the growth curves in multiple cell lines, each day for two days for the 95 RCA input comparison and the kit comparison, and two days post-transfection for the sequential 96 RCA experiment. Viral titer was then determined using plaque assays on Vero cells. number PM100), 1 µl of 1 ng/µl of plasmid DNA was mixed with 4 µl of sample buffer while 108 the thermocycler was preheated to 95°C. The mixture was incubated at 95°C for 1 minute and 109 then rapidly cooled to 4°C. 5 µl of 2x SuperPhi Master Mix was then mixed with the sample, 110 which was then incubated for 16 hours at 30°C before polymerase inactivation at 65°C for 10 111 minutes. For the GenomiPhi V3 DNA Amplification Kit (GE Healthcare), 1 µl of 10 ng/µl of 112 plasmid DNA was mixed with 9 µl of molecular grade water and 10 µl of denaturation buffer. At 113 the same time, the thermocycler was preheated to 95°C. The mixture was incubated for one 114 minute at 95°C and then rapidly cooled to 4°C. 20 µl of the denatured template was then added 115 to the lyophilized reaction cake containing enzymes, dNTPs, and buffers and thoroughly mixed 116 by pipetting. Samples were incubated at 30°C for 90 minutes, and then the enzyme was 117 inactivated at 65°C for 10 minutes. RCA product concentration was determined using Qubit after 118 J o u r n a l P r e -p r o o f a 200-fold dilution in molecular grade water. Amplification of the plasmid was confirmed using 119 endonuclease digestion and gel electrophoresis. Dilutions were performed using molecular grade 120 water. To generate the RCA passages, an initial RCA was performed using the SuperPhi protocol 121 as described above and validated using gel electrophoresis. 1 µl of RCA product was then used 122 as the template for a subsequent 10 µl RCA reaction. We then repeated the process of RCA for a 123 total of three passages. 124

Sequencing Protocol. RCA products were Sanger sequenced at the Genomics Sequencing 125

Center at Virginia Tech. RCA products were diluted to 100 ng/µl to prepare them for 126 sequencing. 1 µl of diluted RCA product was mixed with 3 µl of 1 µM primer and 9 µl of 127 molecular grade water. Resulting reads were aligned using SnapGene® 5.0.7 software (GSL 128 Biotech). there was no difference between viral titers produced by RCA and plasmid in Vero and BHK21 154 cells (p=0.1736 and p=0.6140, respectively). However, the titer of RCA product transfection was 155 significantly higher than the plasmid titer in HEK293T cells (p=0.0027). 156

The above results demonstrate two critical features of using RCA for viral rescue: similar 157 replication kinetics-albeit with a slight delay-and identical peak yield. In all the cell lines, the 158 peak viral titer occurred on the second-day post-transfection for both plasmid and RCA product 159 transfection. These data demonstrate that RCA-rescue is equivalent to plasmid-rescue in its 160 ability to rescue virus using standard transfection conditions in terms of viral yield. A hypothesis 161 for the delay in viral production seen in BHK and HEK293T cells is that the complex structure 162 of RCA products (i.e., branched RCA molecules) compared to plasmid DNA may produce steric 163 inhibition and delay transcription from the CMV promoter by RNA polymerase II [15] . 164

Since the kinetics of virus recovery were similar for all cell lines, and since peak titers 166 were observed two days post-transfection, we only used Vero cells and only sampled on the first-167 and second days following transfection for all future studies. Next, we sought to determine 168 whether transfections with different RCA concentrations would result in efficient virus rescue. 169

To that end, we transfected Vero cells with a range of RCA inputs produced using the Evomics 170

SuperPhi kit (Fig. 3) . One-day post-transfection, 100 ng of RCA resulted in a decreased viral 171 titer compared to a plasmid input of 500 ng (p = 0.0002). We observed no differences in any of 172 the other input concentrations. As in the above experiment, by two days post-transfection, RCA 173 and plasmid titers were the same (100 ng SuperPhi p= .9275, 250 ng SuperPhi p=.9991, 500 ng 174 p>.9999, 1000 ng p=.9952). These results indicate that the transfection of RCA product is robust 175 and can tolerate a wide variety of input concentrations without altering peak viral yield. 176

To ensure that the above results were not restricted to a specific RCA kit, Vero cells 177 were transfected in triplicate in two independent replicates with RCA product produced using 178 both the Evomics SuperPhi Kit and the GE GenomiPhi Kit or plasmid DNA (Fig. 4) . One day 179 post-transfection, the viral titers produced from both 250 ng and 500 ng of GenomiPhi RCA 180 products were lower than the titers produced by plasmid (p = 0.0008 and p = 0.0005, 181 respectively). There was no significant difference between the SuperPhi samples and the plasmid 182 To determine if RCA can further amplify an RCA product without introducing unwanted 189 mutations, an initial RCA was performed using plasmid DNA as a template (subsequently 190 referred to as Passage 0) and amplified three more times. Following the transfection of the 191 different "passages," we found no significant differences between the viral titer produced in 192 passage 0 RCA DNA and plasmid DNA (p= 0.2518) (Fig. 5) . However, we did note a difference 193 between the titers of later RCA passages and plasmid DNA (p = 0.0008, p = 0.0007, and p = 194 0.0016, respectively). To determine if these differences were due to either mutations or artifacts 195 of repeated amplification, RCA DNA from passage 0 and 3 was sequenced using Sanger 196

Sequencing. The sequences for passage 0, passage 3, and the original plasmid were identical, 197 indicating that no mutations were introduced in the viral genome during repeated RCAs. 198 Repeated RCAs may have amplified both specific and non-specific DNA leading to the 199 decreased viral yield. Amplification of non-specific DNA, caused by the concatemerization of 200 the random hexamer primers [26] , alters the ratio of specific to non-specific DNA, resulting in a 201 reduced amount of target DNA for transfection. To mitigate the effect of moderate titer reduction 202 with sequential RCA reaction, harvesting virus at a slightly later time or increasing DNA input 203 may be effective. However, these results indicate that RCA products can effectively act as a 204 template for subsequent RCA reactions without introducing unwanted mutations. RCA products 205

can, therefore, substitute the standard glycerol bacterial stock protocol, or repeated bacterial 206 J o u r n a l P r e -p r o o f transformations to generate midi-or maxi-prepped DNA. In both bacterial methods, mutations 207 can be introduced during growth and, thus, require sequencing. 208

rapidly deployable, compared to the traditional bacterial plasmid platform. 210

The evidence above demonstrates that the RCA platform is equivalent to the plasmid-based 211 platform for generating virus from cDNA infectious clones. However, when considering the time 212 and cost to perform these two processes, it is apparent that RCA offers many advantages (Table  213 1). For the SuperPhi kit, one RCA reaction costs $3.79 and can produce 10 µg of DNA in 16 214 hours. When using the plasmid approach, colonies would need to be selected and screened using 215 endonuclease digestion. An average screening of ten colonies using the Promega PureYield 216 Here, we report a simple method to recover infectious virus from a cDNA clone using RCA 233 to amplify a plasmid. We observed that both RCA and plasmid-based transfection produced 234 similar peak viral titers following transfection for several cell lines, using several RCA kits, and 235 when transfecting variable input DNA amounts. Importantly, RCA products can be reamplified 236 by RCA to maintain a DNA record without generating mutations in the viral genome. Finally, 237 the use of an RCA platform will reduce both the cost and time required to amplify a plasmid 238 stock and rescue virus. Betacoronavirus, Family Coronaviridae). We anticipate that this system can be used for other 254 positive-sense RNA virus cDNA clones and likely negative-strand viruses as well. Moreover, 255 using a CMV promoter allows for simple transfection of small amounts of plasmid DNA without 256 the need for extra reagents to produce viral RNA or potential issues with unwanted mutations 257 derived from the error-prone bacteriophage promoters [7] . However, we have also used a 258 linearized and purified RCA product to generate full-length infectious RNA transcripts from 259 bacteriophage-driven clones, indicating the versatility of this system [29, 30] . Taken together, 260 RCA represents a simple, high-fidelity, and cost-effective means to produce large amounts of 261 plasmid DNA that can be repeatedly propagated and used to rescue infectious virus directly. The kinetics of plasmid and RCA techniques to produce virus were assessed in Vero, BHK21 282

Clone 13, and HEK293T cells. Cells were transfected in triplicate with either 500 ng of Evomics 283

SuperPhi RCA or plasmid DNA in triplicate. The experiment was done in two independent 284 biological replicates. The supernatant was collected each day post-transfection until cells reached 285 90% CPE for plaque assay. Error bars represent the standard deviation from the mean. Statistical 286 analysis was performed using two-way ANOVA with ad hoc Sidak's correction for multiple 287 comparisons (ns P > 0.05, ** P ≤ 0.01, *** P ≤ 0.001). 288 input on viral production kinetics was examined using Vero cells. Cells were transfected in 291 triplicate with 100 ng, 250 ng, 500 ng, or 1000 ng of Evomics SuperPhi RCA or 500 ng of the 292 plasmid. The supernatant was collected at one and 2-days post-transfection for plaque assay. 293

Error bars represent the standard deviation from the mean. Statistical analysis was performed 294

using two-way ANOVA with ad hoc Dunnett's correction for multiple comparisons. 295 296 Fig. 4 Evomics SuperPhi RCA Premix Kit with Random Primers (catalog number PM100). In 318 constructing the cost estimate, it was assumed that ten colonies were selected for screening, and 319 one to four of those colonies were then midiprepped and sequenced. 320 321 322

We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.

We confirm that the manuscript has been read and approved by all named authors and that there are no other persons who satisfied the criteria for authorship but are not listed. We further confirm that the order of authors listed in the manuscript has been approved by all of us.

We confirm that we have given due consideration to the protection of intellectual property associated with this work and that there are no impediments to publication, including the timing of publication, with respect to intellectual property. In so doing we confirm that we have followed the regulations of our institutions concerning intellectual property.

We further confirm that any aspect of the work covered in this manuscript that has involved either experimental animals or human patients has been conducted with the ethical approval of all relevant bodies and that such approvals are acknowledged within the manuscript.

We understand that the Corresponding Author is the sole contact for the Editorial process (including Editorial Manager and direct communications with the office). He is responsible for communicating with the other authors about progress, submissions of revisions and final approval of proofs. We confirm that we have provided a current, correct email address which is accessible by the Corresponding Author and which has been configured to accept email from: james.weger@gmail.com, jmarano@vt.edu, cc6re@vt.edu. Signed by all authors as follows:

Host factors in positive-strand RNA virus genome replication

Haiku: New paradigm for the reverse genetics of emerging RNA viruses

Construction of an infectious Chikungunya virus cDNA clone 327 and stable insertion of mCherry reporter genes at two different sites

From Phase III Dengue Vaccine Efficacy Trials

Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and 332

Successful Propagation of Flavivirus Infectious cDNAs by a Novel 334

Method To Reduce the Cryptic Bacterial Promoter Activity of Virus Genomes

Infectious alphavirus production from a simple plasmid transfection+

Reverse genetics with a full-length infectious cDNA of the Middle East 339 respiratory syndrome coronavirus

Identification of a Cryptic Prokaryotic Promoter within 342 the cDNA Encoding the 5′ End of Dengue Virus RNA Genome

Development and Characterization of Recombinant Virus 345 Generated from a New World Zika Virus Infectious Clone

Exploring the instability of reporters expressed under 348 the subgenomic promoter in Chikungunya virus infectious cDNA clones

The Fitness Effects of Synonymous 350 Mutations in DNA and RNA Viruses

Random Codon Re-encoding Induces Stable Reduction of 353

Replicative Fitness of Chikungunya Virus in Primate and Mosquito Cells

Synonymous mutations at the beginning of the influenza A virus 356 hemagglutinin gene impact experimental fitness

The Discovery of Rolling Circle Amplification and Rolling 358 Circle Transcription

Highly efficient DNA synthesis by the phage Φ29 DNA polymerase

Symmetrical mode of DNA replication

The bacteriophage phi 29 DNA polymerase, a proofreading 363 enzyme

Using barcoded Zika virus to assess virus population structure 365 in vitro and in Aedes aegypti mosquitoes

Molecularly barcoded Zika virus libraries to probe in vivo 367 evolutionary dynamics

Infectious cDNA clones of two strains of 369

Mayaro virus for studies on viral pathogenesis and vaccine development

New reverse genetics and transfection methods to rescue arboviruses in 372 mosquito cells

Generation of High-Yielding Influenza A Viruses in African Green 374

Monkey Kidney (Vero) Cells by Reverse Genetics

Replication of alphaviruses: a review on the 377 entry process of alphaviruses into cells

An alphavirus-based therapeutic cancer vaccine: from design to clinical 380 trial

Alphavirus vectors as tools in neuroscience and gene therapy

Improvements of rolling circle amplification 384 (RCA) efficiency and accuracy using Thermus thermophilus SSB mutant protein

Ensuring safety of DNA vaccines. Microbial cell factories

Development and characterization of infectious clones of two strains of 389 Usutu virus. 2020, Cold Spring Harbor Laboratory

Mosquitoes Transmit Unique West Nile Virus Populations during 391 Each Feeding Episode

Genetic Drift during Systemic Arbovirus Infection of Mosquito 393

Vectors Leads to Decreased Relative Fitness during Host Switching